Cite

    Martina Barone et al.. “Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.” British journal of haematology, vol. 185, 2019, pp. 987–991. http://access.bl.uk/ark:/81055/vdc_100084742422.0x000060